Clinical Trials · NCT06478563

A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity

Name: A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Amycretin

Phase: Phase 1
Recruitment status: Completed
Sponsor: Novo Nordisk A/S
Enrollment: 133
Start date: Jun 2024
Locations: 1 site, United States
Primary endpoint: Phase A: The area under the NNC0487-0111 plasma concentration-time curve during a dosing interval at steady state

View Amycretin compound reference